FGF-1 (Phage Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFGF-1 (Phage Pharmaceuticals)
Drug Alias NameFGF-1 (Phage Pharmaceuticals)
ClassificationSmall molecules
Mechanisms of ActionFibroblast growth factors modulators
TargetsFibroblast growth factors
Therapy Area/IndicationsWounds and InjuriesMyocardial InfarctionEar Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPhage Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhage Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesMyocardial InfarctionEar Diseases

Other Information

ATC CodeN/A
Related LinksN/A